Cadila Healthcare informs about press release

05 Sep 2018 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives final approval from the USFDA for Acyclovir Sodium Injection’.

The above information is a part of company’s filings submitted to BSE. 

Zydus Lifesciences Share Price

1008.15 10.70 (1.07%)
16-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.20
Dr. Reddys Lab 5820.00
Cipla 1423.85
Zydus Lifesciences 1008.15
Lupin 1659.15
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.